THY1 and bronchopulmonary dysplasia: Microscopic observation showed that compared with mice in the BPD group, mice in the anti-CD90 antibody treatment group had better pulmonary pathology, significantly reduced inflammation, and improved alveolar destruction (Fig. 4F).